Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT05731362
Other study ID # 112/2022
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date January 2023
Est. completion date December 2023

Study information

Verified date November 2023
Source University of Limerick
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The MidWest multidisciplinary Community Intervention Teams (MD-CIT) comprise of specialist, healthcare teams that provide a rapid and integrated response to a patient with an acute episode of illness who requires enhanced services/acute intervention for a defined short period of time in the MidWest of Ireland. This is provided in the patient's home, thereby facilitating early discharge from the acute hospital setting. The investigators are performing an evaluation of the MDCIT service provided to older adults admitted to UL Hospitals Group. The investigators will assess patients in hospital, at 30 days and at a six months.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 2023
Est. primary completion date June 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Older adults = 65 years who are discharged home (community dwelling) from ULHG with a referral to the MDCIT service between December 2022 and June 2023 will be deemed eligible for recruitment Exclusion Criteria: - Those aged < 65 years discharged home from ULHG and referred to the MDCIT service - Those deemed to not have decision making capacity to provide informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
MDCIT Intervention
The MidWest Multidisciplinary Community Intervention Teams (MDCIT) comprise of specialist, healthcare teams that provide a rapid and integrated response to a patient with an acute episode of illness who requires enhanced services/acute intervention for a defined short period of time. This is provided in the patient's home after an acute hospital admission, thereby facilitating early discharge. The MDCIT intervention is composed of occupational therapy, physiotherapy, and healthcare assistants, with nursing support as required. The MDCIT therapists aim to make their first visit to patients within 24-48 hours of hospital discharge. Patients receive two-three visits per week, over a period of two to four weeks dependant on the patient's rehabilitation needs. Upon discharge from the MDCIT service, patients can be referred to community services as indicated by therapists.

Locations

Country Name City State
Ireland University Hospital Limerick Limerick

Sponsors (1)

Lead Sponsor Collaborator
University of Limerick

Country where clinical trial is conducted

Ireland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Functional Ability Function will be measured using the Barthel Index (BI). The BI scores a patient from 0-20, with a higher score indicating greater independence. This will be measured at baseline.
Primary Functional Ability Function will be measured using the Barthel Index (BI). The BI scores a patient from 0-20, with a higher score indicating greater independence. This will be measured at 30 days.
Primary Functional Ability Function will be measured using the Barthel Index (BI). The BI scores a patient from 0-20, with a higher score indicating greater independence. This will be measured at 180 days.
Secondary Frailty Score Frailty will be measured using the Clinical Frailty Scale (CFS). The CFS screens for frailty in older adults, with a minimum score of 1 considered least frail and a maximum score of 9 indicating severe frailty. This will be measured at baseline.
Secondary Frailty Score Frailty will be measured using the Clinical Frailty Scale (CFS). The CFS screens for frailty in older adults, with a minimum score of 1 considered least frail and a maximum score of 9 indicating severe frailty. This will be measured at 30 days.
Secondary Frailty Score Frailty will be measured using the Clinical Frailty Scale (CFS). The CFS screens for frailty in older adults, with a minimum score of 1 considered least frail and a maximum score of 9 indicating severe frailty. This will be measured at 180 days.
Secondary Patient Quality of Life Quality of Life will be measured using the EQ-5D-5L. This questionnaire asks a patient to rate their overall perceived health from a scale of 0-100 (0 = very poor; 100 = excellent). This will be measured at baseline.
Secondary Patient Quality of Life Quality of Life will be measured using the EQ-5D-5L. This questionnaire asks a patient to rate their overall perceived health from a scale of 0-100 (0 = very poor; 100 = excellent). This will be measured at 30 days.
Secondary Patient Quality of Life Quality of Life will be measured using the EQ-5D-5L. This questionnaire asks a patient to rate their overall perceived health from a scale of 0-100 (0 = very poor; 100 = excellent). This will be measured at 180 days.
Secondary Quality of Care Quality of Care will be measured using the Patient Assessment of Integrated Elderly Care. Patients are asked 20 questions across a Likert scale from 'none at all' to 'always.' This will be measured at 30 days.
Secondary Quality of Care Quality of Care will be measured using the Patient Assessment of Integrated Elderly Care. Patients are asked 20 questions across a Likert scale from 'none at all' to 'always.' This will be measured at 1800 days.
Secondary Unscheduled ED Attendance(s) ED hospital databases will be searched to identify ED attendances. This will be measured at 30 days.
Secondary Unscheduled ED Attendance(s) ED software will be searched to identify ED attendances. This will be measured at 180 days.
Secondary Unscheduled Hospital Admission(s) ED and hospital software will be searched to identify admissions. This will be measured at 30 days.
Secondary Unscheduled Hospital Admission(s) ED and hospital software will be searched to identify admissions. This will be measured at 180 days.
Secondary Nursing Home Admission(s) Hospital software will be searched to identify patients admitted to nursing homes. This will be measured at 30 days.
Secondary Nursing Home Admission(s) Hospital software will be searched to identify patients admitted to nursing homes. This will be measured at 180 days.
Secondary Mortality Hospital software will be searched to identify patients who pass away. This will be measured at 30 days.
Secondary Mortality Hospital software will be searched to identify patients who pass away. This will be measured at 180 days.
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A